Clinical trial
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid…
NCT00303563 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00303563 |
|---|---|
| Title | A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis |
| Official title | A Randomized, Double-blind Study to Compare the Effect of RO4402257 Monotherapy and Methotrexate Monotherapy on Disease Response in Patients With Active Rheumatoid Arthritis. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | P38 Inhibitor (4), Placebo |
| Enrollment | 204 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | Nov 2, 2016 |
| Countries | Canada, Croatia, Czechia, France, Italy, Mexico, Romania, Serbia, South Africa, Spain, Taiwan, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: